Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2.

Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2.
复制标题

DOI:
10.3390/ijms232012565
复制
发表时间:
2022-10-19
影响因子:
5.6
通讯作者:
--
中科院分区:
生物学2区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

SARS-CoV的功能性受体血管紧张素转换酶2(ACE 2)现在似乎可能介导2019-nCoV进入人类细胞。然而,已经发现了抑制剂如PAP-1和香柠檬素;它们都可以优先结合ACE 2,阻止RBD Spike S蛋白与ACE 2结合,并减少RBD Spike S蛋白的结合位点。此外,我们研究了PAP-1和香柠檬素与ACE 2的结合能,通过分子对接与生物层干涉法(BLI),发现PAP-1和香柠檬素基团之间的相对较高的结合亲和力(KD = 48.5 nM,53.1 nM)。此外,纳摩尔级分对AT-II细胞的生长没有影响,但150 μM PAP-1和75 μM香柠檬素在体外分别抑制了AT-II细胞的增殖75%和68%。同时,它们显著降低ACE 2 mRNA和蛋白水平,分别为67%、58%和55%、41%。这些结果表明,在当前大流行期间,可以进一步开发结合ACE 2蛋白的补骨脂素化合物PAP-1和香柠檬素,以对抗COVID-19感染。但应注意对人肺泡II型上皮细胞的损伤。
Angiotensin-converting enzyme 2 (ACE2), a functional receptor for SARS-CoV, now appears likely to mediate 2019-nCoV entry into human cells. However, inhibitors such as PAP-1 and bergamottin have been discovered; both of them can preferentially bind to ACE2, prevent RBD Spike S protein from binding to ACE2, and reduce the binding sites for RBD Spike S protein. In addition, we investigated the binding energy of PAP-1 and bergamottin with ACE2 through molecular docking with bio-layer interferometry (BLI) and found relatively high binding affinity (KD = 48.5 nM, 53.1 nM) between the PAP-1 and bergamottin groups. In addition, the nanomolar fraction had no effect on growth of the AT-II cell, but 150 µM PAP-1 and 75 µM bergamottin inhibited the proliferation of AT-II cells in vitro by 75% and 68%, respectively. Meanwhile, they significantly reduced ACE2 mRNA and proteins by 67%, 58% and 55%, 41%, respectively. These results indicate that psoralen compounds PAP-1 and bergamottin binding to ACE2 protein could be further developed in the fight against COVID-19 infection during the current pandemic. However, attention should be paid to the damage to human alveolar type II epithelial cells.
COVID-19:新型冠状病毒疾病的演变、传播、检测、控制和预防综述。
DOI: 10.3390/v13020202
发表时间: 2021-01-29
期刊: Viruses
影响因子: --
作者:
Sharma A;Ahmad Farouk I;Lal SK
通讯作者: Lal SK
DOI: 10.1186/s12941-021-00438-7
发表时间: 2021-05-18
影响因子: 5.7
作者:
Mallah SI;Ghorab OK;Al-Salmi S;Abdellatif OS;Tharmaratnam T;Iskandar MA;Sefen JAN;Sidhu P;Atallah B;El-Lababidi R;Al-Qahtani M
通讯作者: Al-Qahtani M
DOI: 10.1016/j.bmcl.2019.126852
发表时间: 2020-02-15
影响因子: 2.7
作者:
Ma, Bin;Lucas, Brian;Richter, Karl
通讯作者: Richter, Karl
DOI: 10.3389/fimmu.2021.589095
发表时间: 2021
影响因子: 7.3
作者:
Chen R;Lan Z;Ye J;Pang L;Liu Y;Wu W;Qin X;Guo Y;Zhang P
通讯作者: Zhang P
DOI: 10.1016/s1473-3099(03)00806-5
发表时间: 2003-11
期刊: The Lancet. Infectious diseases
影响因子: --
作者:
Savarino A;Boelaert JR;Cassone A;Majori G;Cauda R
通讯作者: Cauda R